Secondary mutations across various cancer types were discovered to cause the reversion of DDR protein or gene function, such as BRCA1/2, PALB2, and RAD51C/D, resulting in the restoration of HR repair function and nullifying synthetic lethality [156, 157]. This evidence concerns the gene PALB2 and cancer.